Pharma Pulse: Latest Developments
Welcome to Pharma Pulse, a Pharmaceutical Commerce podcast where we bring you the latest insights shaping patient access, supply chain/logistics, data & tech, and healthcare innovation.
New Research and Acquisitions
This episode discusses new research linking cholesterol imbalance in obesity to higher depression risk.
- Eli Lilly’s acquisition of Aderum Biotechnologies to strengthen its neuroscience pipeline
- Cambrex’s $120 million investment to boost US API manufacturing capacity
From new insights into the metabolic roots of depression to strategic biotech acquisitions and manufacturing growth, these stories underscore how science, business, and infrastructure continue to drive pharma’s evolution.
No specific quotes are available in this text.
Author summary: Pharma Pulse covers latest pharma news.
More News
- Milei, the two Caputos and the two anchors
- “A Nation Held Hostage by Crooks”: Professor Chirwa Tears Into Mutharika’s Chaotic Appointments, Says Malawi Is Being Looted Piece by Piece - Malawi Nyasa Times - News from Malawi about Malawi
- Stubb recalled his first meeting with Tokayev and was pleased to see Finnish brands in Astana
- At 25, Damu school still in shambles Malawi 24 | Latest News from Malawi
- In Review: Big Ass Sword by Andreas Butzbach
- The Betami-Danblock Trial: Randomized Discontinuation Of Beta-Blockers After Myocardial Infarction
- Honkarakenne Brings Finnish Timber Construction Expertise to Kazakhstan – Two New Memoranda of Understanding Signed to Advance Sustainable Tourism and Ecological Solutions
- DELLA-MATTIA: Caputo has right to personal opinion, social media page
- Grokipedia launches after brief crash, accused of copying Wikipedia content - Tech Digest
- Stubb to Tokayev: “There’s no time to be slow in Kazakhstan“